Subscribe To Our Free Newsletter |
Alembic Pharma gets USFDA nod for hypertension treatment drug
Alembic Pharmaceuticals has announced that it has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg.